Pfizer (PFE) Shares Sold by ING Groep NV

Lloyd Doyle
April 25, 2018

The Bbva Compass Bancshares Inc holds 374,270 shares with $13.56M value, down from 385,894 last quarter. Rwc Asset Management Llp who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $220.43 billion market cap company. About 10,365 shares traded. Pfizer Inc. (NYSE:PFE) has risen 2.43% since April 24, 2017 and is uptrending. The stock underperformed the S&P500 by 9.12%. BMO Capital Markets maintained Pfizer Inc.

The stock increased 1.33% or $0.83 during the last trading session, reaching $63.18. By buying 115.00M shares Bank Of America Corp made the stock sank with 3.13%. (NYSE:HD) has risen 18.94% since April 24, 2017 and is uptrending. It has outperformed by 12.83% the S&P500.

Investors sentiment increased to 1.06 in Q4 2017.

Analysts expect Hydrogenics Corporation (NASDAQ:HYGS) to report $-0.11 EPS on May, 11.They anticipate $0.07 EPS change or 38.89% from last quarter's $-0.18 EPS. It increased, as 51 investors sold PFE shares while 675 reduced holdings. 134 funds took holdings and 632 increased holdings. Concorde Asset Management Ltd Llc invested 0.31% of its portfolio in Pfizer Inc. (NYSE:PFE). Biltmore Wealth Management Limited Liability Company holds 0.66% of its portfolio in Pfizer Inc. (NYSE:PFE) for 867,363 shares. Pfizer accounts for about 0.7% of ING Groep NV's portfolio, making the stock its 28th biggest position. Glob X Mngmt Co Limited Com reported 252,057 shares stake. Jefferies maintained Pfizer Inc. Cable Hill Partners LLC now owns 5,051 shares of the biopharmaceutical company's stock valued at $170,000 after buying an additional 308 shares during the period. Renaissance Tech Ltd Co stated it has 1.11M shares. Illinois-based First American Natl Bank has invested 0.49% in Pfizer Inc. Farmers Merchants Investments invested in 170,259 shares. Delphi Private Advisors LLC raised its position in Pfizer by 84.3% in the 4th quarter. (NYSE:PFE) on Monday, February 26. Alps owns 1.39 million shares for 0.35% of their portfolio. Virtu Ltd Liability Com invested 0% of its portfolio in Catalyst Pharmaceuticals, Inc. Fort Washington Oh holds 340,179 shares. Finally, Sumitomo Mitsui Trust Holdings Inc. boosted its stake in Pfizer by 1.4% in the 4th quarter. During the same quarter previous year, the firm posted $0.47 EPS. PFE's profit would be $4.34 billion giving it 12.69 P/E if the $0.73 EPS is correct. The biopharmaceutical company reported $0.62 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.56 by $0.06.

Since December 15, 2017, it had 0 insider purchases, and 12 selling transactions for $12.99 million activity. Confluence Inv Mgmt Limited Company has 1.59% invested in Pfizer Inc. MACKENZIE ALEXANDER R sold 6,750 shares worth $249,750.


PFE opened at $36.80 on Tuesday. (NYSE:PFE) shares were sold by HILL CHARLES H. Another trade for 13,986 shares valued at $501,398 was sold by Dolsten Mikael. CORNWELL W DON also sold $64,679 worth of Pfizer Inc. $353,677 worth of stock was sold by LUND-JURGENSEN KIRSTEN on Saturday, February 24. (NYSE:CALX) or 31,533 shares. (NYSE:PFE). Pioneer Tru Fincl Bank N A Or invested 0.4% of its portfolio in Pfizer Inc.

Rwc Asset Management Llp, which manages about $8.81 billion and $1.89 billion US Long portfolio, upped its stake in Caesars Entmt Corp (NASDAQ:CZR) by 873,011 shares to 888,011 shares, valued at $11.23M in 2017Q4, according to the filing. Two research analysts have rated the stock with a sell rating, twelve have given a hold rating and nine have issued a buy rating to the stock. Therefore 54% are positive. Alibaba had 171 analyst reports since August 12, 2015 according to SRatingsIntel. Goldman Sachs set a $36.00 target price on Pfizer and gave the company a "neutral" rating in a research report on Tuesday, January 30th. The firm has "Buy" rating given on Wednesday, August 2 by Piper Jaffray. The company has an average rating of "Hold" and a consensus target price of $37.37. Oak Point Wealth Management bought a new position in shares of Pfizer in the 4th quarter worth $165,000. (NYSE:PFE) on Tuesday, December 1 with "Equal-Weight" rating. The firm has "Outperform" rating by RBC Capital Markets given on Thursday, November 3. The rating was maintained by Roth Capital with "Buy" on Friday, October 27. BMO Capital Markets set a $39.00 target price on Pfizer and gave the stock a "buy" rating in a report on Monday, January 8th. (NYSE:PFE) shares. $2.39 million worth of Pfizer Inc. Halsey Assocs Ct holds 0.29% or 46,640 shs in its capital. (NYSE:CALX), 4 have Buy rating, 0 Sell and 2 Hold. They expect $0.70 earnings per share, up 3,600.00% or $0.72 from last year's $-0.02 per share. The firm has a market capitalization of $218,053.44, a price-to-earnings ratio of 13.89, a P/E/G ratio of 1.83 and a beta of 0.90. After $0.45 actual earnings per share reported by ConocoPhillips for the previous quarter, Wall Street now forecasts 55.56% EPS growth. The firm has "Hold" rating by Zacks given on Friday, August 14. Therefore 71% are positive. On Monday, February 26 the stock rating was maintained by Jefferies with "Hold". The stock has "Overweight" rating by Morgan Stanley on Friday, October 2. The rating was upgraded by Barclays Capital to "Overweight" on Tuesday, November 29. The rating was initiated by Seaport Global with "Hold" on Tuesday, June 6. The stock has "Outperform" rating by Cowen & Co on Tuesday, October 20. The firm has "Buy" rating by Scotia Capital given on Monday, April 9. Morgan Stanley set a $41.00 price objective on shares of Pfizer and gave the company a "buy" rating in a research note on Friday, January 5th. The rating was maintained by Buckingham Research with "Neutral" on Thursday, September 17.

Investors sentiment decreased to 0.6 in 2017 Q4.

Its weekly performance is 0.74% while year to date (YTD) performance is 1.60%. It dropped, as 14 investors sold Calix, Inc. shares while 24 reduced holdings.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. 193.75 million shares or 3.04% less from 199.84 million shares in 2017Q3 were reported. Bridges Investment Counsel Inc holds 36,362 shares or 0.73% of its portfolio. (NYSE:CALX). Wedge Cap Management L Ltd Partnership Nc invested 0.01% in Calix, Inc. Bell Comml Bank reported 0.08% in Calix, Inc. Brown Advisory stated it has 1,505 shares.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER